Search for: "BRISTOL-MYERS SQUIBB" Results 601 - 620 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2016, 6:11 am by Michael Bersani
,  lawsuits are swarming around the creators of the drugs (Bristol-Myers Squibb and Otsuka Pharmaceuticals for Abilify, Pfizer and Boehringer Ingelheim for Mirapex). [read post]
16 Dec 2011, 3:19 pm
It is the center for major corporate office and research facilities, including Merrill Lynch, Bristol-Myers Squibb, Princeton University Plasma Research Physics Lab, and GE Communications. [read post]
11 Jan 2022, 11:45 am by luiza
Bristol-Myers Squibb is not the first manufacturer to run into issues with the program. [read post]
11 Jan 2022, 11:45 am by luiza
Bristol-Myers Squibb is not the first manufacturer to run into issues with the program. [read post]
9 Oct 2011, 4:35 pm by Lawrence B. Ebert
Merck, Johnson & Johnson, Eli Lilly and Bristol-Myers Squibb also cut jobs. [read post]
17 Feb 2017, 12:21 pm by Amy Howe
Bristol-Myers Squibb Co. v. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
25 May 2021, 3:00 am by Avery Welker
., International Shoe, Bristol-Myers Squibb, Daimler A.G., etc.). [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
24 Apr 2019, 3:00 am by John Jenkins
In late February, Wellington, which runs $359 billion for Vanguard, announced it would oppose Bristol-Myers Squibb ’s plan to acquire Celgene. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
Francis Rooney (R-FL) wrote a letter to the FTC, urging the agency to investigate Bristol-Myers Squibb Company’s (“Bristol-Myers”) acquisition of Celgene Corporation (“Celgene”). [read post]
4 Oct 2019, 10:55 am by Robert Whitman and Hillary Massey
  Noting that the First Circuit has not addressed the question, the court described two divergent approaches taken by district courts around the country on the personal jurisdiction issue:  some courts, with which the Chavira court agreed, have ruled that the Supreme Court’s decision in Bristol-Myers Squibb Co. v. [read post]
24 May 2012, 4:23 am by Max Kennerly, Esq.
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]
25 Feb 2012, 10:04 am by Schachtman
Bristol-Myers Squibb Co., 938 F.2d 1544 (2d Cir. 1991)   Fenfluramine, Phentermine In re Diet Drugs Prod. [read post]
5 Apr 2011, 6:01 pm by Thom Lambert
  to join Bristol Myers Squibb and GlaxoSmithKline in their efforts to prevent the illegal production of patented AIDS drugs in Africa? [read post]